Home > Insider Trading > Filing (0000899243-23-006751)

Filing Details

Accession Number:: 0000899243-23-006751
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-03-02 16:30:31
Reporting Period:: 2023-02-28

Accepted Time:: 2023-03-02 16:30:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Madrigal Pharmaceuticals Inc.	MDGL	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1876996	E. Robert Waltermire	C/O Madrigal Pharmaceuticals, Inc. 200 Barr Harbor Drive, Suite 200 West Conshohocken PA 19428	Senior Vp, Chief Pharma Dev.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-02-28	5,000	$87.92	10,667	No	4	M	Direct
Common Stock	Disposition	2023-02-28	900	$271.03	9,767	No	4	S	Direct
Common Stock	Disposition	2023-02-28	4,100	$272.30	5,667	No	4	S	Direct
Common Stock	Acquisiton	2023-03-01	5,000	$87.92	10,667	No	4	M	Direct
Common Stock	Disposition	2023-03-01	1,928	$273.44	8,739	No	4	S	Direct
Common Stock	Disposition	2023-03-01	1,672	$274.57	7,067	No	4	S	Direct
Common Stock	Disposition	2023-03-01	1,300	$275.53	5,767	No	4	S	Direct
Common Stock	Disposition	2023-03-01	100	$276.19	5,667	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-02-28	5,000	$0.00	5,000	$87.92
Common Stock	Stock Option (Right to Buy)	Disposition	2023-03-01	5,000	$0.00	5,000	$87.92

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,000		2031-08-02	No	4	M	Direct
25,000		2031-08-02	No	4	M	Direct

Footnotes

All shares issued pursuant to the exercise of the options reported herein represent 10,000 shares underlying an overall option award of 35,000 shares. All exercised options had vested. As to the overall option for 35,000 shares, 25% of the shares underlying the option vested on August 2, 2022 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.58 to $271.47, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.82 to $272.77, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.00 to $274.00, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.06 to $274.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.18 to $276.18, inclusive.